Adimmune

Adimmune announced a planned overseas manufacturing site in Indonesia, launching its global expansion

Adimmune Corporation (4142) announced today that its first overseas manufacturing site will be

Onward to Southeast Asia, Adimmune Corporation and Innovalues signed MOU

Adimmune Corporation (4142) announced on the 25th that Adimmune Corporation, Enimmune Corp., an

Adimmune Corporation successfully bid for the procurement of public tender seasonal influenza vaccines, continues its global market expansion

Taiwan Centers for Disease Control (CDC) of Ministry of Health and Welfare announced today that

Adimmune Corporation precisely predicted the WHO recommended strains of seasonal influenza virus to ensure

World Health Organization (WHO) announced in late February the recommended seasonal influenza v

Adimmune Corporation is developing the next generation of COVID-19 vaccines, commencing clinical trial overseas

Adimmune Corporation (4142) announced that in response to the emerging variants of SARS-CoV-2 a

Adimmune Corporation and Korean Pharma signed an agreement for international collaboration on biosimila

Adimmune Corporation (4142) announced the signing of an agreement with SCD, a leading ophthalmi

Adimmune Biotech Corporation(4142) is determined and committed to continue developing the COVID-19 vaccine

Adimmune Biotech Corporation pointed out, after receiving the government's official notificatio

Prepared for the international markets Adimmune Biotech Corporation appointed Dr. Chun Cheng Chen as the Chief Medical Officer

Adimmune Biotech Corporation(4142) announced today, beginning January 2021 Dr. Chun

Adimmune COVID-19 Vaccine Production Team Welcomes JHL Biotech, Inc

Adimmune Biotech Corporation(4142) announced today that it has signed a Master Service Agreemen

Adimmune Biotech Corporation’s COVID-19 vaccine entered the human clinical test phase. Taiwan’s unlocking from the epidemic is to be expected in the near future

Adimmune Biotech Corporation’s(4142) COVID-19 vaccine entered Phase 1 human clinical test this

Adimmune Biotech Corporation signed a $4.2 billion syndicated loan agreement, the sufficient funds would invigorate the company’s future business expansion

Adimmune Biotech Corporation(4142) secured a $4.2 billion syndicated loan today. Adimmune Chair

Adimmune Biotech Corporation applied permit for COVID-19 vaccine human clinical experiment

Adimmune Biotech Corporation(4142) held its 2020 shareholders meeting today. In the meeting it

During a visit to Adimmune Biotech Corporation(4142), Executive Yuan Premier Cheng Chang Su expressed his high expectations for the company’s success in developing the COVID-19 vaccine

Today, the Executive Yuan Premier Cheng Chang Su and his administrative team visited Adimmune B

Adimmune visited by Executive Yuan, promises to deliver COVID-19 vaccine

Adimmune Biotech Corporation(4142), today welcomed the scie

COVID-19 Epidemic drives demand for influenza vaccine

Adimmune Biotech Corporation(4142) April revenue came in at

COVID-19 Vaccine proven effective, Adimmune COVID-19 vaccine antibody response is excellent

When the COVID-19 epidemic first broke out in January 2020,

Adimmune’s new COVID-19 vaccine clinical trials confirms vaccine effectiveness

Adimmune Biotech Corporation(4142) announced today, Adimmun

Adimmune strives to turn losses into profit this year, as profit margins turn from negative to positive

Adimmune Biotech Corporation(4142) announced today that rev

AIT visit Adimmune

Adimmune production line expansion on schedule and will accelerate COVID-19 vaccine development

Adimmune Biotech Corporation(4142), announced today that Fe